This session examines how genetic, genomic, epigenetic, and molecular variations influence immune function, disease susceptibility, treatment response, and clinical outcomes. It includes immune-related gene discovery, pharmacogenomics, personalized risk assessment, molecular classification, precision diagnostics, and individualized therapeutic strategies.
Abstracts may present genomic studies, biomarker research, patient stratification, computational analyses, rare disease findings, and clinical applications of precision medicine. The session welcomes immunologists, geneticists, clinicians, bioinformaticians, molecular scientists, laboratory professionals, and industry researchers working to advance personalized approaches in immune-mediated diseases.